An Intranasal OMV-based vaccine induces high mucosal and systemic protecting immunity against a SARS-CoV-2 infection
P. A. van der Ley, A. Zariri, E. van Riet, D. Oosterhoff, C. P. Kruiswijk
This paper develops an intranasal OMV-based vaccine that induces strong mucosal and systemic immunity against SARS-CoV-2, offering protection against viral infection in animal models.
bioRxiv · Aug 25, 2021Immunology